|
|
|
Celexa - Class Action Information
|
The SSRI Celexa has been linked with suicide, suicidal ideation and violence in children and teenagers. Celexa is used
to treat depression. The antidepressant medication Celexa is thought to work by boosting serotonin levels in the brain.
Serotonin, one of the nervous system's primary chemical messengers, is known to elevate mood. Celexa has been prescribed
as a treatment for depression to more than 30 million patients worldwide, including 8 million in the United States.
Antidepressants increased the risk of suicidal thinking and behavior (suicidality) in short-term studies in children and
adolescents with Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of Celexa or
any other antidepressant in a child or adolescent must balance this risk with the clinical need. Patients who are started
on therapy should be observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and
caregivers should be advised of the need for close observation and communication with the prescriber. Celexa is not approved
for use in pediatric patients.
On October 15, 2004, the FDA ordered that all antidepressants, such as Celexa, must carry the government's "black box" safety
alert to warn that the drugs are linked to increased suicidal thoughts and behavior among children and teens. The warning came
after two days of public hearings of the FDA's Psychopharmacologic Drugs and Pediatric Advisory Committees (PDAC), where
testimony by victims, parents and experts, in combination with previous testimony from the PDAC's hearing in February was
presented. The committee voted 15-to-8 for a "Black Box" warning for children and adolescents after reviewing clinical-trial
data that showed the drugs are twice as likely as a placebo to cause suicidal thoughts or behavior.
Return to Main
|
|
